Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03288194
Other study ID # 15-1619
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2015
Est. completion date April 24, 2017

Study information

Verified date May 2022
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study has been designed to test the efficacy of telephone-delivered Problem-Solving Treatment (PST) for improving the quality of life (QoL) in outpatients with stable heart failure (HF).


Description:

Heart failure (HF) is the end stage of all cardiovascular diseases, and it imposes a huge burden in the United States in terms of morbidity, mortality, and economic cost. Although disease management programs have been developed to curb these costs and address the complexities of HF management, evaluations of these programs have yielded equivocal results. With this study the Investigators plan to: (1) to determine the feasibility of telephone delivered PST for outpatients with HF and reduced QoL by obtaining estimates of yield, retention, patient acceptance, and patient satisfaction; (2) to determine whether telephone-delivered PST is associated with greater improvements in QoL than telephone-delivered Time Management over 8 weeks; and (3) to determine whether telephone-delivered PST is associated with greater reductions in depressive symptoms and/or greater improvements in self-efficacy or objectively assessed daily physical activity than telephone-delivered Time Management over 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date April 24, 2017
Est. primary completion date April 24, 2017
Accepts healthy volunteers No
Gender All
Age group 21 Years to 99 Years
Eligibility Inclusion Criteria: - Outpatient - Age > 21 - Exhibits symptoms of hear failure (NYHA Class II or III) - Left ventricular ejection fraction (LVEF) >= 40% - Kansas City Cardiomyopathy Questionnaire (KCCQ) summary score < 60 Exclusion Criteria: - Cannot speak English - Lack telephone access - Unwilling to be randomized, or - Unavailable for the study period - Awaiting a heart transplant (United Network for Organ Sharing Status 1A or 1B), or - Planned (within 6 months) cardiac surgery - Cognitive impairment indicative of dementia - Recent (3 months) - acute myocardial infarction, - cardiac decompensation, or - HF-related hospitalization. - Use intravenous inotropic medication - Use an assistive circulatory device - Significantly reduced life expectancy due to co-morbidity (e.g., malignancy) - Currently receiving mental health counseling; - A history of: - bipolar disorder, - psychosis, or - substance abuse/dependency - Severe depressive symptoms or suicidality

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Problem-Solving Treatment

Time Management


Locations

Country Name City State
United States University of Colorado Denver Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Kansas City Cardiomyopathy Questionnaire The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. 1 month, 2 months, 3 months, 4 months, 5 months
Secondary Change in Beck Depression Inventory The Beck Depression Inventory is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression. 1 month, 2 months, 3 months, 4 months, 5 months
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy